Carlyle Group’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.1M | Hold |
860,980
| – | – | 1.43% | 2 |
|
|
2025
Q1 | $61.4M | Sell |
860,980
-514,666
| -37% | -$36.7M | 1.62% | 2 |
|
|
2024
Q4 | $61.8M | Sell |
1,375,646
-2,695,916
| -66% | -$121M | 1.49% | 2 |
|
|
2024
Q3 | $205M | Hold |
4,071,562
| – | – | 21.52% | 2 |
|
|
2024
Q2 | $166M | Hold |
4,071,562
| – | – | 15.8% | 3 |
|
|
2024
Q1 | $173M | Buy |
4,071,562
+1,213,758
| +42% | +$51.6M | 10.91% | 3 |
|
|
2023
Q4 | $115M | Buy |
2,857,804
+564,242
| +25% | +$22.7M | 5.53% | 3 |
|
|
2023
Q3 | $67.4M | Buy |
2,293,562
+1,092,056
| +91% | +$32.1M | 2.92% | 5 |
|
|
2023
Q2 | $5.09M | Hold |
1,201,506
| – | – | 0.18% | 18 |
|
|
2023
Q1 | $2.54M | Buy |
+1,201,506
| New | +$2.54M | 0.08% | 23 |
|